Deutsche Bank
TCON

Deutsche Bank’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Deutsche Bank’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7
Closed -$1K – 4442
2021
Q3 		$1K Sell
7
-12,674
-100% -$1.07M ﹤0.01% 4382
2021
Q2 		$1.65M Hold
12,681
– – ﹤0.01% 2405
2021
Q1 		$2.09M Buy
+12,681
New +$2.44M ﹤0.01% 2143
2018
Q4 		– Sell
-305
Closed -$125K – 5478
2018
Q3 		$125K Hold
305
– – ﹤0.01% 4423
2018
Q2 		$165K Buy
305
+31
+11% +$16.5K ﹤0.01% 4357
2018
Q1 		$126K Buy
274
+190
+226% +$104K ﹤0.01% 4406
2017
Q4 		$56K Buy
+84
New +$50.7K ﹤0.01% 4415

Other funds holding TCON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Deutsche Bank's TCON Position: Q4 2021 in Review

Deutsche Bank sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2021, closing a stake of 7 shares — an estimated $1K sold.

Deutsche Bank first reported a position in TCON in Q4 2017 and held it in 7 quarters. The position peaked at $2.09M in Q1 2021. 35 funds tracked by Wall St. Rank hold TCON as of Q4 2021.

  • Deutsche Bank reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Deutsche Bank sold 7 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $1K.
  • Deutsche Bank first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 7 quarters.
  • Deutsche Bank's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $2.09M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.